Supplier site
Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Managed Markets Insight & Technology LLC (MMIT)

Managed Markets Insight & Technology LLC (MMIT) is listed as a large business research supplier in the Scientist.com network, with 1 site in 1 country.

View Managed Markets Insight & Technology LLC (MMIT) on Scientist.com

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: Large business

Clinical Consulting

Regulatory Consulting Ensure that each product or device complies with all FDA rules and regulations.
Study Budgeting Consulting Request for Consulting Services

Clinical Trials

Study/Site Feasibility Study Explore and test study practicality.
Synthetic Control Arm Creation Using RWD Using patient data from sources like electronic health records or claims databases to construct a comparator group for clinical trials, instead of enrolling a separate group of control patients.

HEOR

Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.

Show all 12 in HEOR 6 more

Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.

Market Access

Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.

Show all 11 in Market Access 5 more

Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
Payer Toolkit Communicate product value to payers utilizing digital and mobile technology (For example, Payer-Facing iPad Models).
Population Health Analytics Aggregation of patient data across multiple health information technology resources, the analysis of that data into a single, actionable patient record, and the actions through which care providers can improve both...
Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Study Start Up Consulting Request for RWE/HEOR/Market Access Study Start Up Consulting

Show all 89 services 73 more

Medical Communications

Adverse Events Reports Collecting, documenting, and forwarding reports of side effects or safety issues experienced by patients to the pharmacovigilance team for regulatory reporting.
Disease Care Pathway Transformation Partner with health systems to analyse disease pathways across primary and secondary care. Identify pain points and partner with health system stakeholders to solve pain points, leading to better patient...
Gap Analysis Compare the actual performance of an organization or corporation with potential or desired performance, as ways to effectively analyze resource management or allocation.
HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
Landscape Analysis Find a cohesive and consistent view of your main organization. Develop initiatives in analyzed areas of operations and analyze chosen key aspects of them.
Market & Competitor Analyses Evaluating the current therapeutic landscape, identifying unmet needs, and assessing the scientific positioning and data of competitor products.

Show all 15 in Medical Communications 9 more

Medical Affairs Services for non-promotional scientific exchange, supporting the dissemination of accurate medical data and the development of educational content.
Medical Affairs Dossiers Develop medical affairs dossiers such as Global Value Dossiers or AMCP Dossiers.
Medical Publications Make clear and accurate presentations of scientific and technical data.
New Product/Indication Launch Planning Strategic development of the medical affairs communication road map and activities necessary to support the successful introduction of a new therapy or approved use.
Poster Design and Development Design and Develop Posters for Poster Symposiums and conferences to effectively convey science information.
Poster Symposia, Summits, Product Theaters, etc. Support Comprehensive planning and execution support for organized, large-scale medical meetings and events used to present and discuss clinical data and research.
Publication Writing Create further publication documents. Investigational device exemptions (IDEs) BLAs, MAA, PMA, eCTDs, informed consents, CMC and manufacturing reports, orphan drug designations (ODD), briefing books.
Publications Plan Development & Management Strategic planning and oversight of all research dissemination activities, including outlining target journals, timelines, authors, and compliance for clinical data publications.
Therapy Area Disease Insights Report Creation of a comprehensive analysis of the current scientific, clinical, and competitive landscape within a specific therapeutic area.

Medical/Commercial

Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.

Old Category HEOR, RWE, Market Access

Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
RWE/HEOR/Market Access Disease/Clinical Outcomes Study the course of disease and the possible outcome of disease, including expected frequency.
RWE/HEOR/Market Access Hybrid Study Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
RWE/RWD Enriched Studies Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.

Primary Market Research

Adherence, Satisfaction, and Switch Behavior Studies Explores factors driving treatment compliance, satisfaction, and switching behavior. Guides patient support initiatives and product differentiation.
Competitive Landscape Research Maps competitor products, positioning, trial activity, and perception among stakeholders. Delivers inputs for SWOT analysis and differentiation strategy.
Forecast Input Generation Provides validated data points for input into financial or epidemiologic models. Supports accurate revenue, market share, and volume forecasting.
Journey Mapping (Patient, HCP, Payer) Visual representation of stakeholder experiences across disease or treatment timelines. Identifies pain points, decision triggers, and opportunities for engagement or support.
Launch Readiness Assessments Evaluates internal and external preparedness for product launch, including sales force, market awareness, and access environment. Identifies gaps and supports launch planning.
Market Opportunity Assessments Quantifies addressable market size, unmet needs, and competitive landscape. Supports go/no-go decisions and commercial forecasting.

Show all 10 in Primary Market Research 4 more

Product Landscape and Unmet Needs Reports Synthesizes secondary data and expert input into landscape maps and gap analyses. Informs asset development and positioning.
Segmentation and Profiling Divides target audiences into distinct groups based on attitudes, behaviours, or demographics. Informs tailored messaging and targeting strategies.
Strategic Recommendations for Brand Teams Delivers synthesized insights and data-driven strategic guidance to commercial teams. Supports brand planning and lifecycle management.
Trial Feasibility and Design Preference (HCP/patient) Gathers stakeholder input on protocol practicality, site selection, and enrollment design. Reduces recruitment barriers and aligns trials with real-world practice.

Real World Evidence & Data

Claims Data & Database Analysis Analysis of care cost and quality.
Claims Data - Billing Includes patient demographics, insurance status, geographical location, among others.
Claims Data - Medical Includes hospitalization,physician visits,emergency department visits. May or may not include laboratory information including resource utilization, costs or charges, as well as ICD-9 or 10 codes.
Claims Data - Pharmacy Includes medications, prescription orders, payment submissions, patient adherence, among others.
Clinical Phenotype Data Obtain phenotypic data and observations on patients such as the clinical manifestation of the disease, clinical and behavioral parameters, symptoms, and laboratory test results.
Cohort Study Investigating the causes of disease to establish links between risk factors and health outcomes.

Show all 28 in Real World Evidence & Data 22 more

Data Merging Tools for combining various data sets into a single data set. Includes data consolidation.
Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
Payer Outcomes-Based Contract Trial Study or analysis of data (claims, electronic HR/MR) to assess reimbursement or price to actual health outcomes.
Predictive Analytics Variety of statistical techniques from data mining, predictive modeling, and machine learning, that analyze current and historical facts to make predictions about future or otherwise unknown events.
Pregnancy Registries Database containing, through utilizing observational research methods, standardized data about women taking medication or vaccines while pregnant. Data may also collected on the newborn.
Quantitative or Qualitative Research Either to understand concepts, thoughts, or experiences with qualitative research or to quantify the problem by generating numerical data or data that can be transformed into usable statistics with quantitative research.
Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
Retrospective Exploratory Studies Retrospective exploratory studies
RWD - COVID-19 Data from COVID-19 patients, can include diagnosis, treatment, among others.
RWD - Diagnostics/Laboratory Includes information on laboratory procedures/results.
RWD - Electronic Medical Record (EMR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
RWD - Genomics Genomic data collected from a patients with different diseases, can be derived from a range of sources.
RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
RWE/HEOR/Market Access Safety Surveillance Monitor safety of treatment and determine methods to identify adverse events early
RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
Post-authorization Safety Studies Research efforts conducted after a drug has been approved for market to monitor its safety profile in the general population. These studies aim to identify, characterize, or quantify potential adverse effects...
Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.
Safety Signals Early indication that a new or unknown adverse event occurred that may be caused by treatment and investigation is needed to determine a causal relationship. Can be investigated through spontaneous reports, studies...

Website: www.MMIT.com

United States Yardley 1 site

Work with Managed Markets Insight & Technology LLC (MMIT) on Scientist.com

For prices, more details, or to contact Managed Markets Insight & Technology LLC (MMIT), visit Scientist.com.

View on Scientist.com